(BUSINESS WIRE)--Covidence is a clinical development service organization and was formed from the clinical research, medical writing, pharmacovigilance, data management and biostatistics departments of Global Pharma. It provides full clinical drug development services to the research-based pharmaceutical and biotechnology industry. Nearly two hundred highly skilled and experienced staff members deliver the highest possible quality on regional and global projects ranging from phase one to phase four studies in addition to global submissions. The excellence of our professionals is demonstrated by a strong track record in a wide range of clinical indications, including
oncology cardiovascular disorders diabetology disorders endocrine disorders musculo-skeletal disease dermatology vaccines and plasma proteins. Over the past five years more than 30.000 patients have participated in our global clinical studies at over 3.000 investigator sites on four continents.
For more information, please visit www.covidence.com.
Company: Covidence GmbH
Headquarters Address: Helfmann-Park 2 Eschborn (Frankfurt) 65760 Germany
Main Telephone: +49 6196 7709-0
Type of Organization: Private
Industry: Health: Pharmaceutical
Key Executives: CEO: Luc Opsomer Managing Director: Horn Wilhelm Managing Director: L?ffler Kurt
Customer Service Contact: Michael Stephan Phone: +49 6196 7709-327 Email: email@example.com
Customer Service Contact: Martine van Brandt Phone: +49 6196 7709-310 Email: firstname.lastname@example.org
Public Relations Contact: Sonja Riebel Phone: +49 6196 7709-339 Email: email@example.com
Source: Covidence GmbH